Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1904628-10-9Apixaban Impurity C

● Auf Lager

Katalog-Nr.::	VE009137
CAS-Nr.::	1904628-10-9
Summenformel::	C27H28N4O6
Molare Masse::	504.54 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 1904628-10-9

Parent drug

Apixaban

IUPAC-Name

2-Hydroxyethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo[3, 4-c]pyridine-3-carboxylate

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

Smile

O=C1CCCCN1C2=CC=C(N3CCC(C(C(OCCO)=O)=NN4C5=CC=C(OC)C=C5)=C4C3=O)C=C2

InChI

InChI=1S/C27H28N4O6/c1-36-21-11-9-20(10-12-21)31-25-22(24(28-31)27(35)37-17-16-32)13-15-30(26(25)34)19-7-5-18(6-8-19)29-14-3-2-4-23(29)33/h5-12,32H,2-4,13-17H2,1H3

Beschreibung

Apixaban Impurity C standard is a well-characterized compound that aligns with key regulatory guidelines, including USP, EMA, JP, and BP. It plays a crucial role in analytical method development, method validation (AMV), and quality control (QC) processes, particularly in the manufacturing of Apixaban. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), ensuring reliable and precise analytical outcomes.